We are live on ! Find out more
BCV

Banque Cantonale Vaudoise Portfolio holdings

AUM $722M
1-Year Est. Return 30.45%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+30.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.55B
AUM Growth
+$250M
Cap. Flow
+$77.9M
Cap. Flow %
3.05%
Top 10 Hldgs %
36%
Holding
1,098
New
76
Increased
327
Reduced
363
Closed
105

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$32.4M
2
PM icon
Philip Morris
PM
+$20.1M
3
PFE icon
Pfizer
PFE
+$6.37M
4
COR icon
Cencora
COR
+$5.23M
5
EA icon
Electronic Arts
EA
+$4.68M

Sector Composition

Rank Sector Weight
1 Technology 27.97%
2 Financials 17.41%
3 Healthcare 14.29%
4 Consumer Staples 9.77%
5 Consumer Discretionary 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNX icon
951
TD Synnex
SNX
$20.4B
$5K ﹤0.01%
45
VAL.WS icon
952
Valaris Ltd Warrants
VAL.WS
$684M
$5K ﹤0.01%
424
OXY.WS icon
953
Occidental Petroleum Corp Warrants
OXY.WS
$33B
$4K ﹤0.01%
93
FTH
954
Faeth Therapeutics
FTH
$702M
$4K ﹤0.01%
195
TAC icon
955
TransAlta
TAC
$3.95B
$4K ﹤0.01%
633
TLRY icon
956
Tilray
TLRY
$618M
$4K ﹤0.01%
201
SPI
957
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$4K ﹤0.01%
5,857
AMRN
958
Amarin Corp
AMRN
$299M
$3K ﹤0.01%
180
-21
-10% -$448
AWR icon
959
American States Water
AWR
$3.36B
$3K ﹤0.01%
35
-123
-78% -$9.17K
CNXC icon
960
Concentrix
CNXC
$1.5B
$3K ﹤0.01%
45
CVAC
961
DELISTED
CureVac
CVAC
$3K ﹤0.01%
1,000
FELE icon
962
Franklin Electric
FELE
$4.63B
$3K ﹤0.01%
27
-95
-78% -$9.38K
HRTX icon
963
Heron Therapeutics
HRTX
$93.9M
$3K ﹤0.01%
1,000
PLUR icon
964
Pluri
PLUR
$16.7M
$3K ﹤0.01%
400
AVTX icon
965
Avalo Therapeutics
AVTX
$965M
$2K ﹤0.01%
+338
New +$1.82K
GRPN icon
966
Groupon
GRPN
$1.05B
$2K ﹤0.01%
183
+33
+22% +$503
HUT
967
Hut 8
HUT
$12.1B
$2K ﹤0.01%
+157
New +$1.38K
IRBT
968
DELISTED
iRobot
IRBT
$2K ﹤0.01%
217
KLG
969
DELISTED
WK Kellogg Co
KLG
$2K ﹤0.01%
82
-579
-88% -$8.42K
NABL icon
970
N-able
NABL
$882M
$2K ﹤0.01%
143
NVAX icon
971
Novavax
NVAX
$1.2B
$2K ﹤0.01%
500
OGN icon
972
Organon & Co
OGN
$3.56B
$2K ﹤0.01%
118
TXMD icon
973
TherapeuticsMD
TXMD
$23.5M
$2K ﹤0.01%
1,000
ADPT icon
974
Adaptive Biotechnologies
ADPT
$3.59B
$1K ﹤0.01%
300
BB icon
975
BlackBerry
BB
$4.98B
$1K ﹤0.01%
500

Similar funds

Banque Cantonale Vaudoise's Q1 2024 Portfolio in Review

As of Q1 2024, Banque Cantonale Vaudoise held 1,098 positions worth $2.55B, up 11% from $2.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Banque Cantonale Vaudoise deployed $77.9M of net new capital in Q1 2024, opening 76 new positions and adding to 327 existing holdings. Its largest new stake was Duke Energy: 45,299 shares worth $4.38M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.84M trimmed.

  • Banque Cantonale Vaudoise's largest Q1 2024 buy was Duke Energy: 45,299 shares worth $4.38M.
  • Banque Cantonale Vaudoise added most to UBS Group in Q1 2024, an estimated $32.4M increase.
  • Banque Cantonale Vaudoise's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.84M.
  • Banque Cantonale Vaudoise fully exited Cooper Companies in Q1 2024, selling an estimated $2.82M.
  • Banque Cantonale Vaudoise's ten largest holdings make up 36% of its $2.55B portfolio in Q1 2024.
  • Banque Cantonale Vaudoise opened 76 new positions and closed 105 in Q1 2024.
  • Banque Cantonale Vaudoise's portfolio value rose 11% quarter-over-quarter to $2.55B.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.